المؤلفون: N.I. Weijl, Carin A. Uyl-de Groot, Lidwine W. Tick, Andre M. Bergman, Winald R. Gerritsen, Daan ten Bokkel Huinink, Hans M. Westgeest, Jules Lavalaye, Katja K.H. Aben, Inge M. van Oort, Fons A.J.M. van den Eertwegh, Malou C.P. Kuppen, Menuhin I. Lampe, Yes A J van de Wouw, Jeroen R.J.A. van Moorselaar, Joan van den Bosch, Juleon L.L.M. Coenen, Rik D.M. Somford, Tineke J. Smilde, Niven Mehra, Mathijs P. Hendriks

المساهمون: Internal medicine, CCA - Cancer biology and immunology, Urology, CCA - Cancer Treatment and quality of life, Health Technology Assessment (HTA)

المصدر: Westgeest, H M, Kuppen, M C P, van den Eertwegh, F A J M, van Oort, I M, Coenen, J L L M, van Moorselaar, J R J A, Aben, K K H, Bergman, A M, Huinink, D T B, van den Bosch, J, Hendriks, M P, Lampe, M I, Lavalaye, J, Mehra, N, Smilde, T J, Somford, R D M, Tick, L, Weijl, N I, van de Wouw, Y A J, Gerritsen, W R & Groot, C A U 2021, ' High-Intensity Care in the End-of-Life Phase of Castration-Resistant Prostate Cancer Patients : Results from the Dutch CAPRI-Registry ', Journal of Palliative Medicine, vol. 24, no. 12, pp. 1789-1797 . https://doi.org/10.1089/jpm.2020.0800Test
Journal of Palliative Medicine, 24(12), 1789-1797. Mary Ann Liebert Inc.
Journal of Palliative Medicine, 24, 12, pp. 1789-1797
Journal of Palliative Medicine, 24, 1789-1797

مصطلحات موضوعية: Male, medicine.medical_specialty, Medical Overuse, Castration resistant, Prostate cancer, SDG 3 - Good Health and Well-being, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], Humans, Medicine, Registries, General Nursing, Netherlands, Retrospective Studies, Terminal Care, business.industry, High intensity, General Medicine, medicine.disease, Prostatic Neoplasms, Castration-Resistant, Anesthesiology and Pain Medicine, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Emergency medicine, Hospital admission, business, End-of-life care, Life phase

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df4add06b482c8b42c6f4158cc5bdf89Test
https://research.vumc.nl/en/publications/13bcb35e-f6d1-4c15-a1e8-8d67db323f51Test

المؤلفون: Katja K.H. Aben, Carin A. Uyl-de Groot, Joan van den Bosch, Inge M. van Oort, Saskia van der Meer, Andries M. Bergman, Jules L.L.M. Coenen, Winald R. Gerritsen, Diederik M. Somford, Hans M. Westgeest, Jules Lavalaye, Alphons C.M. van den Bergh, Mathijs P. Hendriks, Maarten J. van der Doelen, Malou C.P. Kuppen, Filiz Celik, Marco B. Polee, Alphonsus J. M. van den Eertwegh

المساهمون: Medical oncology, CCA - Cancer Treatment and quality of life, CCA - Imaging and biomarkers, Health Technology Assessment (HTA), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: Kuppen, M C, Westgeest, H M, van der Doelen, M J, van den Eertwegh, A J, Coenen, J L, Aben, K K, van den Bergh, A C, Bergman, A M, den Bosch, J V, Celik, F, Hendriks, M P, Lavalaye, J, der Meer, S V, Polee, M B, Somford, D M, van Oort, I M, Uyl-de Groot, C A & Gerritsen, W R 2020, ' Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer ', Future Oncology, vol. 16, no. 19, pp. 1371-1384 . https://doi.org/10.2217/fon-2020-0039Test
Future Oncology, 16(19), 1371-1384. Future Medicine Ltd.
Future Oncology, 16, 19, pp. 1371-1384
Future oncology, 16(19), 1371-1384. FUTURE MEDICINE LTD
Future Oncology, 16, 1371-1384

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Treatment completion, Databases, Factual, radium-223, THERAPY, RECOMMENDATIONS, Prostate cancer, DOUBLE-BLIND, 0302 clinical medicine, Aged, 80 and over, BONE METASTASES, Real world outcomes, CYCLES, General Medicine, sequencing, Middle Aged, real-world outcomes, Survival Rate, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], 030220 oncology & carcinogenesis, TRIAL, medicine.drug, Radium, Radium-223, medicine.medical_specialty, PHASE-3, Antineoplastic Agents, Bone Neoplasms, Castration resistant, survival, Drug Administration Schedule, Double blind, EVENTS, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Internal medicine, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], medicine, Humans, Radium-223 Dichloride, Aged, Retrospective Studies, Radioisotopes, Window of opportunity, business.industry, medicine.disease, EFFICACY, skeletal-related events, 030104 developmental biology, metastatic castration-resistant prostate cancer, EXPERIENCE, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b016678894ad456a0d9a4e1e94d887b8Test
https://pure.eur.nl/en/publications/f28d6113-b2c9-48d2-b4bf-904818fb828dTest

المؤلفون: Paul J.M. Kil, Carin A. Uyl-de Groot, Johanna J.M. Takkenberg, Hans M. Westgeest, Kevin M Veen, M. Mostafa Mokhles, Isabel B. de Angst, Winald R. Gerritsen, Malou C.P. Kuppen

المساهمون: Cardiothoracic Surgery, Health Technology Assessment (HTA)

المصدر: Journal of Cancer Research and Clinical Oncology, 146, 2067-2075. Springer-Verlag
Journal of Cancer Research and Clinical Oncology, 146, 2067-2075
Journal of Cancer Research and Clinical Oncology, 146, 8, pp. 2067-2075
Journal of Cancer Research and Clinical Oncology

مصطلحات موضوعية: Male, Cancer Research, Review – Clinical Oncology, Computer science, Clinical Decision-Making, Machine learning, computer.software_genre, 01 natural sciences, 010104 statistics & probability, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Lasso (statistics), SDG 3 - Good Health and Well-being, medicine, Humans, 030212 general & internal medicine, Registries, 0101 mathematics, Castration-resistant prostate cancer, Netherlands, Proportional Hazards Models, Retrospective Studies, Models, Statistical, Proportional hazards model, business.industry, General Medicine, Missing data, medicine.disease, Decision Support Systems, Clinical, Regression, Prostatic Neoplasms, Castration-Resistant, Specification, Oncology, Prediction modeling, Cox proportional hazard model, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Regression Analysis, Artificial intelligence, business, computer, Statistician, Coding (social sciences), Decision-making

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3417c1289a73f67b18a369cc28e6a76eTest
https://pure.eur.nl/en/publications/d9c008f1-f498-4ef5-94d3-42786d5f1a55Test

المؤلفون: Malou C.P. Kuppen, Niven Mehra, Maarten J. van der Doelen, Marcel J.R. Janssen, Marianne A. Jonker, Inge M. van Oort, Winald R. Gerritsen

المصدر: Clinical Nuclear Medicine, 43, 1, pp. 9-16
Clinical Nuclear Medicine, 43, 9-16

مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, MEDLINE, Bone Neoplasms, Rare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9], Castration resistant, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, Prostate cancer, All institutes and research themes of the Radboud University Medical Center, 0302 clinical medicine, Daily practice, Internal medicine, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], medicine, Overall survival, Humans, Radiology, Nuclear Medicine and imaging, In patient, GeneralLiterature_REFERENCE(e.g.,dictionaries,encyclopedias,glossaries), Aged, Proportional Hazards Models, Retrospective Studies, Aged, 80 and over, Proportional hazards model, business.industry, Retrospective cohort study, General Medicine, Middle Aged, medicine.disease, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], Prostatic Neoplasms, Castration-Resistant, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], 030220 oncology & carcinogenesis, business, Radium

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e93594dfcb645d9162cf545e7db8015bTest
https://doi.org/10.1097/rlu.0000000000001904Test

المؤلفون: Daniel Vargas Pivato de Almeida, Sabine Schmid, Hiroyoshi Suzuki, Celestia S. Higano, Rafael Morales-Barrera, Elisa Ledet, Kostas Karalis, Ursina Zürrer-Härdi, Aurelius Omlin, Andries M. Bergman, Aaron R. Hansen, Elena Castro, Dirk Klingbiel, Pernelle Lavaud, William Oh, Nieves Martinez Chanza, Steven Yip, Malou C.P. Kuppen, Tomasz M. Beer, Silke Gillessen, Himisha Beltran, Che-Kai Tsao, Fernando C. Maluf, Ugo De Giorgi, Christopher Sweeney, Carmel Pezaro, Oliver Sartor, Giuseppe Di Lorenzo, Vincenza Conteduca, Marcello Tucci, Niven Mehra, Andrea Zivi, Kim N. Chi, Mo Linh Le, Diletta Bianchini, Sämi Schär

المساهمون: Institut Català de la Salut, [Schmid S] Department of Medical Oncology and Haematology, Cantonal Hospital of St Gallen, St Gallen, Switzerland. Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. [Omlin A] Department of Medical Oncology and Haematology, Cantonal Hospital of St Gallen, St Gallen, Switzerland. [Higano C] Seattle Cancer Care Alliance, University of Washington, Seattle. [Sweeney C, Martinez Chanza N] Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. [Mehra N] Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. [Morales-Barrera R] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, Health Technology Assessment (HTA)

المصدر: Università degli studi di Foggia-IRIS
JAMA Network Open
Scientia
JAMA network open, 3(10). American Medical Association
JAMA Network Open, 3
JAMA Network Open, 3, 10

مصطلحات موضوعية: Pròstata - Càncer - Quimioteràpia, Oncology, ADN - Reparació, medicine.medical_specialty, Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Male::Prostatic Neoplasms [DISEASES], Combination therapy, Population, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Other subheadings::Other subheadings::/drug therapy [Other subheadings], Prostate cancer, SDG 3 - Good Health and Well-being, Nutritional and Metabolic Diseases::Metabolic Diseases::DNA Repair-Deficiency Disorders [DISEASES], Internal medicine, Medicine, education, Original Investigation, education.field_of_study, business.industry, Research, enfermedades nutricionales y metabólicas::enfermedades metabólicas::trastornos por deficiencias en la reparación del ADN [ENFERMEDADES], Retrospective cohort study, General Medicine, Evaluable Disease, medicine.disease, neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales masculinos::neoplasias de la próstata [ENFERMEDADES], Online Only, Prostate-specific antigen, Docetaxel, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Cohort, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba024468bfdef5a4e348b95e58194637Test
https://fair.unifg.it/handle/11369/407886Test